NetraMark will be attending the International Society for CNS Clinical Trials and Methodology (ISCTM) Autumn Conference on 16-17 September 2026 in Philadelphia, PA, USA.
ISCTM is an independent, multi-disciplinary, non-profit organization devoted to improving clinical research by promoting advances in clinical research methods related to the development of central nervous system (CNS) therapeutics. The Autumn Conference will focus on improving clinical trial design, regulatory science, and novel endpoints, attended by experts from regulatory agencies, academia, and the pharmaceutical industry.
Send us a message or set up a time to chat with our attending team below!
Attending Team
Dr. Luca Pani
Chief Innovation and Regulatory Officer, NetraMark
Dr. Jan Sedway, PhD
Senior VP, Clinical Science, NetraMark
What Is NetraAI?
NetraAI is an AI-driven clinical intelligence platform, purpose-built to analyze all collected participant data across small, complex clinical trial datasets.
Designed to address the challenges of heterogeneity, NetraAI reveals patient-level response structure that informs sponsors and biotechs of the minimal baseline characteristic combinations found to be driving treatment response and placebo response signals across trial populations.
Access to this data that is often obscured by traditional population averaging enables sponsors to inform clinical development decisions before future trial designs are locked.